###begin article-title 0
###xml 14 19 <span type="species:ncbi:9606">Human</span>
Biomarkers of Human Exposure to Acrylamide and Relation to Polymorphisms in Metabolizing Genes
###end article-title 0
###begin p 1
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.
###end p 1
###begin p 2
###xml 1005 1006 1005 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1153 1154 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1357 1358 1357 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1415 1416 1415 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1503 1504 1503 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Acrylamide (AA) is formed in heat treated carbohydrate rich foods in the so-called Maillard reaction. AA is readily absorbed in the body and converted to glycidamide (GA) by epoxidation by the CYP2E1 (cytochrome P450 2E) enzyme. Both AA and GA may be detoxified through direct conjunction to glutathione by glutathione-S-transferases and GA by hydrolysis to glyceramide. Recently, we reported that biomarkers of AA exposure reflect intake of major food sources of AA; there were large interindividual variations in the blood ratio of GA-Hb/AA-Hb (GA- and AA-hemoglobin adducts). In this study we investigated whether the ratio of GA-Hb/AA-Hb in subjects could be related to polymorphic differences in genes coding for metabolizing enzymes CYP2E1, EPHX1 (microsomal epoxide hydrolase), GSTM1, GSTT1, and GSTP1, all being expected to be involved in the activation and detoxification of AA-associated adducts. We found significant associations between GSTM1 and GSTT1 genotypes and the ratio of GA-Hb/AA-Hb (p = 0.039 and p = 0.006, respectively). The ratio of GA-Hb/AA-Hb in individuals with the combined GSTM1- and GSTT1-null variants was significantly (p = 0.029) higher than those with the wild-type genotypes. Although the number of subjects was small, there were also significant associations with other combinations; CYP2E1 (Val179Val) plus GSTM1-null (p = 0.022); CYP2E1 (Val/Val), GSTM1-null plus GSTT1-null (p = 0.047); and CYP2E1 (Val/Val), GSTT1 null, EPHX1 (Tyr113Tyr) plus EPHX1 (His139Arg) (p = 0.018). Individuals with these combined genotypes had significantly higher blood ratio of GA-Hb/AA-Hb than other combinations. The observed associations correspond with what would be expected from the relative roles of these enzymes in activation and detoxification of AA, except for individuals with the EPHX1 (His139Arg) variant. The internal dose of genotoxic metabolite and also the concentration of AA in blood seem to be affected by these polymorphic genes. The genotypes and their combination may constitute useful biomarkers for the assessment of individual susceptibility to AA intake, and could add to the precision of epidemiological studies of dietary cancer.
###end p 2
###begin p 3
###xml 133 141 133 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Ho, 2006</xref>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 278 298 278 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Mottram <italic>et al.</italic>, 2002</xref>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 300 320 300 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Stadler <italic>et al.</italic>, 2002</xref>
###xml 407 418 407 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">IARC (1994)</xref>
###xml 614 615 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 687 706 687 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Sumner <italic>et al.</italic>, 1992</xref>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">1997</xref>
###xml 881 887 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 872 893 872 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Ghanayem <italic>et al.</italic>, 2005</xref>
###xml 902 908 902 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 895 914 895 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Sumner <italic>et al.</italic>, 1999</xref>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 986 1008 986 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Dearfield <italic>et al.</italic>, 1995</xref>
###xml 1020 1026 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1010 1032 1010 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Segerback <italic>et al.</italic>, 1995</xref>
###xml 1244 1250 1244 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1237 1256 1237 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Kirman <italic>et al.</italic>, 2003</xref>
###xml 1511 1512 1511 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1575 1576 1575 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1629 1635 1629 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1622 1641 1622 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Sumner <italic>et al.</italic>, 1992</xref>
###xml 1760 1768 1760 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
###xml 1801 1808 1801 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1881 1887 1881 1887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1874 1893 1874 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Doerge <italic>et al.</italic>, 2005</xref>
###xml 1905 1911 1905 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1895 1917 1895 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Tornqvist <italic>et al.</italic>, 2002</xref>
###xml 2167 2173 2167 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2160 2179 2160 2179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Hagmar <italic>et al.</italic>, 2005</xref>
###xml 447 453 <span type="species:ncbi:9606">humans</span>
The Maillard reaction is responsible for the formation of browning products contributing to color, odor and taste of processed food (Ho, 2006). Maillard browning reaction products from mainly glucose and asparagine are responsible for the formation of acrylamide (AA) in foods (Mottram et al., 2002; Stadler et al., 2002). The presence of AA in foods caused considerable concern because AA is classified by IARC (1994) as probably carcinogenic to humans (2A). AA is readily absorbed and metabolized in the body. A major detoxification pathway is glutathione conjugation, resulting in urinary excretion of N-acetyl-S-(3-amino-3-oxopropyl) cysteine, a mercapturic acid derivative (MA-AA) (Sumner et al., 1992, 1997). An alternative metabolic pathway is the CYP2E1 (cytochrome P450 2E1) dependent oxidation of AA, from which the genotoxic epoxide glycidamide (GA) is formed (Ghanayem et al., 2005; Sumner et al., 1999). GA reacts readily with DNA and other macromolecules forming adducts (Dearfield et al., 1995; Segerback et al., 1995) and this is probably the main pathway responsible for the carcinogenic effect of AA. GA may, however, also be further metabolized by epoxide hydrolase (EPHX1) to glyceramide, which is excreted in urine (Kirman et al., 2003) or conjugated to glutathione, and these reactions represent deactivation pathways and therefore compete with the formation of GA adducts. Following a stepwise conversion, the GA-glutathione conjugates are excreted as the urinary MA derivatives N-acetyl-S-(3-amino-2-hydroxy-3-oxopropyl)cysteine (MA-GA3) and N-acetyl-S-(carbamoyl-2-hydroxyethyl)cysteine (MA-GA2) (Sumner et al., 1992). There are nonenzymatic pathways for the transformation of AA and GA but these are considered to be less significant in vivo. AA may also interact covalently in vivo with proteins forming different types of macromolecular adducts (Doerge et al., 2005; Tornqvist et al., 2002). Hemoglobin (Hb) adducts of AA and GA represent an integral of AA and GA concentrations present in the circulation over the lifetime of the erythrocytes (about 4 months) and reflect therefore the average exposure to AA over the last months (Hagmar et al., 2005).
###end p 3
###begin p 4
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 683 695 683 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Autrup, 2000</xref>
###xml 1190 1196 1190 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1181 1202 1181 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Ghanayem <italic>et al.</italic>, 2005</xref>
###xml 1211 1217 1211 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1204 1223 1204 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Sumner <italic>et al.</italic>, 1999</xref>
###xml 914 919 <span type="species:ncbi:9606">human</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1084 1088 <span type="species:ncbi:10090">mice</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
Genes coding for enzymes involved in the biotransformation of carcinogens can be used as markers of individual susceptibility to cancer because different activity of these enzymes may increase or decrease the conversion of a xenobiotic into its reactive metabolite. A large number of chemical carcinogens are biotransformed to more toxic metabolites by phase I activation enzymes, such as CYPs or to nontoxic compounds by phase II detoxification enzymes, such as glutathione-S-transferase (GSTs). Many enzymes involved in either activation or detoxification of chemical carcinogen metabolism are polymorphically expressed, with the alleles presenting different enzymatic activities (Autrup, 2000). CYP2E1 is an enzyme responsible for the metabolic activation of many carcinogens, including AA; this inducible and major CYP isoform is mainly expressed in the liver, but is also found at significant levels in other human tissues. The important role of CYP2E1 in epoxidation of AA to GA and formation of GA-DNA adducts has been demonstrated 100 by using CYP2E1-null mice, and when such mice were exposed to AA, higher levels of AA-adducts were observed compared with wild-type mice (Ghanayem et al., 2005; Sumner et al., 1999).
###end p 4
###begin p 5
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 464 485 464 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Benhamou <italic>et al.</italic>, 1998</xref>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 487 507 487 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Hassett <italic>et al.</italic>, 1994</xref>
###xml 618 619 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 675 699 675 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Hosagrahara <italic>et al.</italic>, 2004</xref>
###xml 712 718 712 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 701 724 701 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Omiecinski <italic>et al.</italic>, 2000</xref>
The microsomal EPHX1 is involved in the metabolism of highly reactive epoxide intermediates and presumably also GA, to the less reactive and water-soluble glyceramide. It has been shown that the activity of the enzyme EPHX1 is affected by two polymorphisms; a substitution of 113Tyr to 113His in exon 3 corresponds to a 40% decrease in the enzyme activity, whereas a substitution of 139His to 139Arg in exon 4 corresponds to a 25% increase in the enzyme activity (Benhamou et al., 1998; Hassett et al., 1994). It has been shown that the resulting activity of EPHX1 depends on its expression level, measured with benzo[a]pyrene-4,5-oxide and cis-stilbene oxide as substrates (Hosagrahara et al., 2004; Omiecinski et al., 2000).
###end p 5
###begin p 6
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 148 170 148 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Mannervik <italic>et al.</italic>, 1992</xref>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 172 190 172 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Meyer <italic>et al.</italic>, 1991</xref>
###xml 444 450 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 434 456 434 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Ali-Osman <italic>et al.</italic>, 1997</xref>
###xml 458 469 458 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Board, 1981</xref>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 471 490 471 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Pemble <italic>et al.</italic>, 1994</xref>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 492 510 492 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Peter <italic>et al.</italic>, 1989</xref>
###xml 901 907 901 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 894 913 894 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Cotton <italic>et al.</italic>, 2000</xref>
###xml 915 938 915 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Hayes and Strange, 1995</xref>
###xml 1142 1154 1142 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Autrup, 2000</xref>
###xml 97 103 <span type="species:ncbi:9606">humans</span>
###xml 337 343 <span type="species:ncbi:9606">humans</span>
###xml 894 900 <span type="species:ncbi:3635">Cotton</span>
GSTs constitute a superfamily of at least 13 isoenzymes belonging to five different families, in humans designated alpha, gamma, mu, pi, and theta (Mannervik et al., 1992; Meyer et al., 1991). GSTs are known to play important roles in the defense system against damaging effects of oxidative stress as well as reactive electrophiles. In humans, there are three GST genes, GSTM1, GSTT1, and GSTP1, with known functional polymorphisms (Ali-Osman et al., 1997; Board, 1981; Pemble et al., 1994; Peter et al., 1989). Because the specificity and also expression level of the GST isoenzymes affect the biotransformation of most toxic electrophiles, the existence of different variants of the enzymes may influence the detoxification efficiency. The homozygous deletion polymorphisms of the GSTM1 and GSTT1 genes, as well as the GSTP1 105Val allele polymorphism, are known to alter enzyme activities (Cotton et al., 2000; Hayes and Strange, 1995). It has been suggested that individuals who are environmentally exposed to carcinogens and also carry genetic variants of genes for phase I or phase II enzymes, have a higher risk of developing cancer (Autrup, 2000). This may also apply to AA, a possibility which is explored in the present work.
###end p 6
###begin p 7
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 84 105 84 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 271 292 271 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 425 446 425 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 668 674 668 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 659 680 659 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 1004 1010 1004 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 997 1016 997 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Vesper <italic>et al.</italic>, 2008</xref>
Recently, we reported on methods to determine the Hb adducts of AA and GA in blood (Bjellaas et al., 2007). These biomarkers of exposure to AA were quantified in blood samples from volunteers and correlated to dietary intake as recorded in food frequency questionnaires (Bjellaas et al., 2007). The relationship between the estimated dietary intake of AA and Hb adducts in this cohort has been described in detail elsewhere (Bjellaas et al., 2007). We found significant correlations between the biomarkers and major known food sources of AA. The molar ratio between GA-derived and AA-derived Hb adducts varied considerably (ninefold) between the individuals (Bjellaas et al., 2007), and the varying ratio of GA-Hb/AA-Hb among individuals could not be explained by the AA intake alone. This could reflect individual differences in metabolizing capacity. Recently, it was reported that there are large variations in AA-Hb and GA-Hb adducts between individuals, and between subpopulations in Europe (Vesper et al., 2008). We have therefore characterized our study subjects with respect to polymorphisms in CYP2E1, EPHX1, GSTM1, GSTT1, and GSTP1, and explored associations between given combinations of these polymorphisms and the amount of AA and GA adducts as well as their ratio.
###end p 7
###begin title 8
METHODS
###end title 8
###begin title 9

###end title 9
###begin title 10

###end title 10
###begin title 11
Subjects.
###end title 11
###begin p 12
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 548 569 548 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 254 266 <span type="species:ncbi:9606">participants</span>
###xml 430 442 <span type="species:ncbi:9606">participants</span>
###xml 830 842 <span type="species:ncbi:9606">participants</span>
Forty-seven nonsmoking employees at the Norwegian Institute of Public Health accepted an invitation to participate in the study. In addition, six smokers were recruited through personal invitation. There were no exclusion criteria, but samples from four participants (two male and two female) were left out of the study because all of the blood had been used for adduct measurement. In total, the study population consisted of 49 participants, 18 males, and 31 females. A detailed description of the subjects was also given in our previous report (Bjellaas et al., 2007). Two males and four females were smokers (12% of the study population); the median number of cigarettes per day was 14 (range 7-21). All individuals examined were Caucasians. The Regional Ethics Committee and the Data Inspectorate approved the study, and all participants gave their written informed consent.
###end p 12
###begin title 13
Determination of hemoglobin adducts of AA and GA.
###end title 13
###begin p 14
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 320 341 320 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 421 440 421 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Olesen <italic>et al.</italic>, 2008</xref>
Hb adducts of AA and GA were determined as phenylthiohydantoin derivatives and quantified using liquid chromatography with an ion trap tandem mass spectrometric detection in negative electrospray ionization mode. The preparation of blood samples and determination of Hb adducts have been described in detail previously (Bjellaas et al., 2007), and the same methods for the determination of Hb adducts were used recently (Olesen et al., 2008).
###end p 14
###begin title 15
Genotyping.
###end title 15
###begin p 16
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 617 642 617 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Abdel-Rahman <italic>et al.</italic>, 1996</xref>
###xml 781 787 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 774 793 774 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Ryberg <italic>et al.</italic>, 1994</xref>
###xml 932 938 932 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 925 944 925 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Ryberg <italic>et al.</italic>, 1994</xref>
Genomic DNA was extracted from frozen whole blood from the 49 subjects using BloodPrep Chemistry on the ABI PRISM 6100 Nucleic Acid PrepStation (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions, and the quantity and quality of isolated DNA was determined using a NanoDrop Spectrophotometer (Thermo Scientific, Waltham, MA). The presence or absence of GSTM1 and GSTT1 genes were determined with PCR, using GSTM2 as a positive control. The primers used for GSTT1 were 5'-CAT CTC CTT AGC TG ACCT CGT AG-3' and 5'-GGC ATC AGC TTC TGC TTT ATG-3', generating a 412-base pair (bp) fragment (Abdel-Rahman et al., 1996). For GSTM1, the primers were 5'-CTG CCC TAC TTG ATT GAT G-3' and 5'-CTG GAT TGT AGC AGA TCA TGC-3', generating a 276-bp fragment (Ryberg et al., 1994). The primers for GSTM2 were 5'- CTG CCC TAC TTG ATT GAT G-3' and 5'-GAC TCA CTC TGA GCA TAG CAC-3', generating a 165-bp fragment (Ryberg et al., 1994). The absence of a 412- or a 276-bp electrophoretic band in the PCR product indicates the presence of a GSTM1-null or a GSTT1-null genotype, respectively. The presence of a 165-bp band of GSTM2 indicates successful PCR assay.
###end p 16
###begin p 17
The TaqMan single nucleotide polymorphism (SNP) Genotyping Assay was used for CYP2E1, EPHX1, and GSTP1 according to the manufacturer's protocol (Applied Biosystems). Briefly, each reaction mixture (13.75 mul) of polymerase chain reaction contained 50 ng of DNA, 12.50 mul of 2x TaqMan Universal PCR Master Mix, No AmpErase UNG, and 1.25 mul of 20x TaqMan SNP Genotyping Assay Mix (primers and probes specific for each polymorphism) (Applied Biosystems). Amplification was done under the following conditions: 50degreesC for 2 min, 95degreesC for 10 min followed by 50 cycles of 92degreesC for 15 s and 60degreesC for 1.5 min. Data were analyzed using Allelic Discrimination Program (Applied Biosystems). For each polymorphism, all 49 DNA samples were genotyped at least twice to confirm the results. The primer and probe used were: CYP2E1 Val179Ile polymorphism (rs6413419), CYP2E1 Phe421Phe polymorphism (rs2515641), EPHX1 Tyr113His polymorphism (rs1051740), EPHX1 His139Arg polymorphism (rs2234922), and GSTP1 Ile105Val polymorphism (rs1695), and all reagents and the 7500Fast Real-Time PCR System are from Applied Biosystems (Applied Biosystems).
###end p 17
###begin title 18
Statistical analysis.
###end title 18
###begin p 19
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The difference in mean molar ratios between the GA and AA Hb adducts in blood was analyzed with the nonparametric, Mann-Whitney U test. The Chi-squared goodness-of-fit test was used to examine the distributions of subjects with the polymorphic genotypes between genders, and this test was also used to compare the allele proportions and to determine whether the CYP2E1, EPHX1, and GSTP1 allelic frequencies conformed with the Hardy-Weinberg equilibrium. Deviations from Hardy-Weinberg equilibrium for GSTM1 and GSTT1 individuals were not tested, because heterozygous individuals could not be distinguished from wild-type by the PCR method used. The level of significance was chosen as p < 0.05. All statistical analyses were performed using SPSS for Windows version 14 (SPSS, Inc., Chicago, IL).
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21

###end title 21
###begin title 22
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 22
###begin p 23
###xml 68 75 68 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
The relevant characteristics of the study subjects are presented in Table 1. Mean age was 41 years (range 24-60) and 45 years (range 26-65) for the 31 females and the 18 males, respectively. The distributions of smoking status among the genders were approximately similar (Table 1).
###end p 23
###begin p 24
Characteristics of the Study Subjects
###end p 24
###begin p 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note.</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Note. *Significantly higher levels of hemoglobin adducts in smokers compared with nonsmokers (p < 0.001 for both), but no significant difference of GA-Hb/AA-Hb ratio in blood between smokers and nonsmokers (p = 0.602). No significant difference of GA-Hb/AA-Hb ratio in blood between male and female (p = 0.163).
###end p 25
###begin title 26
Biomarkers of Exposure in Blood
###end title 26
###begin p 27
###xml 472 473 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 607 614 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 738 744 730 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
The Hb adducts of AA (AA-Hb) and GA (GA-Hb) were detected in all blood samples analyzed, and the mean concentrations for nonsmokers were 40.00 +/- 2.25 pmol/g globin and 20.41 +/- 1.34 pmol/g globin for AA-Hb and GA-Hb, respectively. For smokers, the mean adduct levels were 154.00 +/- 19.00 pmol/g globin and 76.50 +/- 10.74 pmol/g globin for AA-Hb and GA-Hb, respectively. The smokers had significantly higher concentrations of Hb adducts in comparison with nonsmokers (p < 0.001 for both). There were no significant differences between males and females in the ratio of GA-Hb versus AA-Hb adduct levels (Table 1). There was no (all subjects) or a very small (nonsmokers only) association between the ratio of GA-Hb/AA-Hb versus AA-Hb (Fig. 1). The ratio of GA-HB/AA-Hb data for nonsmokers and for all subjects were normally distributed (-).
###end p 27
###begin p 28
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The ratio of GA-Hb/AA-Hb versus AA-Hb, for nonsmokers and for all subjects. For all study subjects, there was no association (R2 = 0.031); excluding smokers a very weak association was observed (R2 = 0.12).
###end p 28
###begin title 29
Genotype Distributions and Association with the Biomarkers of AA Exposure in Blood
###end title 29
###begin p 30
###xml 85 92 85 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 201 208 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 337 361 337 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Fairbrother <italic>et al.</italic>, 1998</xref>
###xml 371 377 371 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 363 383 363 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Hanioka <italic>et al.</italic>, 2003</xref>
###xml 788 826 788 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">The International HapMap Project, 2003</xref>
###xml 838 844 838 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 828 850 828 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Thorisson <italic>et al.</italic>, 2005</xref>
The genotype distributions and allele frequencies of the study subjects are shown in Table 2. The frequencies of the CYP2E1 179Ile allele and CYP2E1 421Phe (T) allele were 0.10 and 0.35, respectively (Table 2). CYP2E1 (Val179Ile) which is a mis-sense transition mutation, has not been shown to have any effect on the enzymatic activity (Fairbrother et al., 1998; Hanioka et al., 2003), whereas CYP2E1 (Phe421Phe) is a silent intronic mutation. The frequencies of the EPHX1 113His allele, EPHX1 139Arg allele, and GSTP1 105Val allele were 0.43, 0.33, and 0.49, respectively. The genotype distributions in this study were in Hardy-Weinberg equilibrium, except for CYP2E1 Phe421Phe allele, and the frequencies of the alleles are in agreement with those found in other Caucasian populations (The International HapMap Project, 2003; Thorisson et al., 2005).
###end p 30
###begin p 31
Genotype Distributions and Allele Frequencies of the Subjects
###end p 31
###begin p 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note.</italic>
Note. There are no significant differences in genotype frequencies between genders, and also no significant differences in genotype distributions between the nonsmokers subjects and all subjects.
###end p 32
###begin p 33
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 319 337 319 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Garte <italic>et al.</italic>, 2001</xref>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 339 358 339 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Nelson <italic>et al.</italic>, 1995</xref>
###xml 360 373 360 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Rebbeck, 1997</xref>
Large variations have been reported in the frequencies of GSTT1 and GSTM1 deletion among different ethnicities. In our study the frequency of GSTT1 null genotype was 51%, and that of GSTM1 null genotype was 18% (Table 2). The range of values reported for Caucasian populations is 10-20% for GSTT1 and 40-50% for GSTM1 (Garte et al., 2001; Nelson et al., 1995; Rebbeck, 1997). Our study subjects hence show a genotype distribution which is unexpected and different from these ranges.
###end p 33
###begin p 34
###xml 315 322 315 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 565 566 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 577 584 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 825 826 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 910 917 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
Because GA is the genotoxic metabolite of AA, a most relevant biomarker of exposure to AA is the molar ratio of GA-Hb and AA-Hb. We therefore tested the association of this biomarker with the various polymorphisms. For the CYP2E1 genotypes, we found no significant association with the ratio of GA-Hb/AA-Hb levels (Table 3). For the EPHX1 genotype, we found that individuals with the EPHX1 139Arg allele in exon 4, corresponding to increased enzyme activity, had significantly higher ratio of GA-Hb/AA-Hb compared with individuals with the wild-type allele 139His (p = 0.007) (Table 3). The 139Arg allele also gave strongly reduced absolute AA-Hb concentrations, which is contrary to what was expected. For the GST genotypes, we found a statistically significant association with the GSTM1 and GSTT1 genotypes (p = 0.039 and p = 0.006, respectively); the GA-Hb/AA-Hb ratio for the null alleles were increased (Table 3). In addition the absolute concentrations of GA-Hb were significantly increased for the null genotypes for both enzymes.
###end p 34
###begin p 35
Genotype Distributions and their Association with the Biomarkers of AA Exposure in Blood
###end p 35
###begin p 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note.</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Note. *Significant associations between GSTT1, GSTM1 and EPHX1 139Arg genotypes and GA-Hb/AA-Hb ratio levels in blood, p < 0.05. **Significant associations between EPHX1 139Arg allele and AA-Hb adduct concentration, p < 0.05. ***Significant associations between GSTM1 and GSTT1 genotypes and GA-Hb adduct concentration, p < 0.05. The numbers in italics indicate the p-value for each calculated association.
###end p 36
###begin p 37
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table 4</xref>
###xml 733 734 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 747 748 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 772 779 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table 4</xref>
###xml 964 965 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 975 982 975 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table 4</xref>
###xml 1564 1565 1564 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1574 1581 1574 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl5">Table 5</xref>
###xml 2112 2118 2112 2118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2100 2124 2100 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Brantsaeter <italic>et al.</italic>, 2008</xref>
The ratio and the absolute concentrations of GA-Hb and AA-Hb adducts were also analyzed with respect to their association with the combined genotypes. We found significant associations between individuals with the double combination variant of GSTM1-null plus GSTT1-null (p = 0.029), and CYP2E1 (Val/Val) plus GSTM1 null (p = 0.022); both the ratio of GA-Hb/AA-Hb and the absolute GA-Hb adduct concentration for these combined variants were significantly higher in comparison with individuals which did not carry these genotype combinations (Table 4). The triple combination CYP2E1 (Val/Val), GSTM1 null and GSTT1 null, was also significantly associated with both increased adduct ratios and the absolute GA-Hb adduct concentration, p = 0.047 and p = 0.033, respectively (Table 4). There was also a significant association between the combination CYP2E1 (Val179Val), GSTT1 null, EPHX1 (Tyr113Tyr), and EPHX1 (His139Arg), and the ratio of GA-Hb/AA-Hb adduct level, p = 0.018 (Table 4). This means that individuals with these combined genotypes have significantly higher blood ratio of GA-Hb/AA-Hb levels, compared with individuals which did not carry these genotypes. Because the smokers had significantly higher AA-Hb and GA-Hb adduct concentration than nonsmokers, we reanalyzed the data for nonsmoking subjects. When the data for the six smokers were excluded and the associations were analyzed for the remaining individuals (43 nonsmokers), we observed similar trends as those for the whole study subjects, but the associations were slightly weaker with higher p values (Table 5). This suggests that the adduct level ratios were not affected by the high AA-Hb concentrations in smokers. The other polymorphic combinations were not statistically significant (data not shown). Attempts to correlate the AA-Hb level with the intake of AA-rich food, from food frequency questionnaires, without taking into account the polymorphisms in biotransformation enzymes, were unsuccessful. In a new study, using a revised database for AA content in various food items, a positive association was indeed found (Brantsaeter et al., 2008).
###end p 37
###begin p 38
Association between Combined Genotypes and Biomarkers of AA Exposure in Blood
###end p 38
###begin p 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note.</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Note. *Significant associations between individuals with the combination variant of GSTM1 null and GSTT1 null, CYP2E1 (Val179Val) and GSTM1 null, CYP2E1 (Val/Val), GSTM1 null and GSTT1 null, and CYP2E1 (Val179Val), GSTT1 null, EPHX1 (Tyr113Tyr) and EPHX1 (His139Arg), and GA-Hb/AA-Hb ratio levels, p < 0.05. **Significant association between individuals with the combination variant of GSTM1 null and GSTT1 null, CYP2E1 (Val179Val) and GSTM1 null, and CYP2E1 (Val/Val), GSTM1 null and GSTT1 null, and GA-Hb adduct concentration, p < 0.05. The presence of the combination of the other genotypes was taken as the reference (or wild-type) group. The numbers in italics indicate the p-value for each calculated association.
###end p 39
###begin p 40
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Association between Genotypes and Biomarkers of AA Exposure in Blood for Nonsmoker Subjects (n = 43)
###end p 40
###begin p 41
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note.</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Note. *Significant association between individuals with the genotype or combination genotype and GA-Hb/AA-Hb adduct ratio levels, p < 0.05. **Significant association between individuals with the genotype or combination genotype and AA-Hb adduct concentration, p < 0.05. ***Significant association between individuals with the genotype or combination genotype and GA-Hb adduct concentration, p < 0.05. The presence of the combination of the other genotypes was taken as the reference (or wild-type) group. The numbers in italics indicate the p-value for each calculated association.
###end p 41
###begin title 42
DISCUSSION
###end title 42
###begin p 43
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 111 132 111 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Ghanayem <italic>et al.</italic>, 2005</xref>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 134 153 134 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Sumner <italic>et al.</italic>, 1999</xref>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 505 525 505 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Schoket <italic>et al.</italic>, 2001</xref>
###xml 466 471 <span type="species:ncbi:9606">human</span>
In rodents, AA is metabolized by CYP2E1 to the genotoxic epoxide GA which forms adducts with DNA and proteins (Ghanayem et al., 2005; Sumner et al., 1999). Conjugation with glutathione is a major detoxification pathway for both AA and GA. Genetic polymorphisms affecting enzymes involved in AA biotransformation could be important determinants of the individual variability of AA metabolism and therefore the individual susceptibility; this also concerns many other human xenobiotic metabolizing enzymes (Schoket et al., 2001).
###end p 43
###begin p 44
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 128 149 128 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bjellaas <italic>et al.</italic>, 2007</xref>
We recently reported major interindividual variations in the dietary intake of AA estimated from food frequency questionnaires (Bjellaas et al., 2007). These were however neither associated with the observed levels of AA-Hb nor the GA-Hb in blood (data not shown). The AA-Hb adduct concentration will be a marker for the internal AA dose, whereas the resulting GA-Hb concentration is a marker of the internal genotoxic dose. By relating the GA-Hb concentration to the AA-Hb concentration in assessing the role of biotransformation enzymes for the internal genotoxic dose, we compensate both for variations in external AA exposure and also for variations in the influence of enzymatic removal of AA. Hence, the ratio of GA-Hb to AA-Hb is expected to be a biomarker of AA-related genotoxic exposure. This ratio varied considerably (ninefold) between the individuals in this study.
###end p 44
###begin p 45
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
Our primary aim was to investigate whether the observed interindividual variations could be related to polymorphic differences in the genes CYP2E1, EPHX1, GSTM1, GSTT1, and GSTP1, either alone or in combination. It would be expected that the net level of GA-Hb-resulting from endogenously formed GA-results from a combination of metabolic reactions as depicted in Figure 2. Maximum GA is expected with the most efficient CYP2E1 genotype, and-at the same time-the least efficient genotypes of GSTM1, GSTP1, GSTT1, and the least efficient genotype of EPHX1. The minimum GA levels would be expected with the inverse genotype combinations.
###end p 45
###begin p 46
Metabolism of AA and GA. The association between AA and its metabolite, with drug metabolizing enzymes.
###end p 46
###begin p 47
We observed that individuals with GSTM1- and GSTT1-null phenotype have significantly higher ratio of GA-Hb/AA-Hb compared with individuals without these genotypes, and these individuals may therefore be prone to increased risk resulting from the decreased enzymatic activity in removal of both AA and GA. The null genotypes were both associated with increased absolute AA- and GA-Hb adduct concentrations.
###end p 47
###begin p 48
###xml 71 78 71 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table 4</xref>
###xml 533 539 533 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 685 691 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 676 697 676 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Benhamou <italic>et al.</italic>, 1998</xref>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 699 719 699 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Hassett <italic>et al.</italic>, 1994</xref>
###xml 853 859 853 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1124 1131 1124 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1392 1398 1392 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1380 1404 1380 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Hosagrahara <italic>et al.</italic>, 2004</xref>
###xml 1417 1423 1417 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1406 1429 1406 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Omiecinski <italic>et al.</italic>, 2000</xref>
Analysis of the combined effects of various combinations of genotypes (Table 4) indicates that individuals with some specific genotype combinations had significantly higher ratio of GA-Hb/AA-Hb in the blood. These combinations were (1) GSTM1- and GSTT1- null; (2) CYP2E1 179Val and GSTM1 null; (3) CYP2E1 179Val, GSTM1 null and GSTT1 null; (4) CYP2E1 179Val, GSTT1 null, EPHX1 113Tyr and EPHX1 139Arg. The observed associations may be explained by the biological roles of these enzymes in activation/deactivation as discussed above (Fig. 2). However, the combination (4) was unexpected because the EPHX1 genotype combinations are assumed to give increased enzymatic activity (Benhamou et al., 1998; Hassett et al., 1994) and a concomitant reduced concentration of GA. The EPHX1 139Arg allele unexpectedly, contrary to our expectations of high activity (Fig. 2), was associated with an increased relative concentration of GA-Hb. In individuals with the EPHX1 139Arg (high activity) alleles, the AA-Hb adduct concentrations were significantly lower (about 50%) than in individuals with the EPHX1 139His (low activity) allele (Table 3). The reason for this is unknown. The exceptional low AA-Hb concentration would be important for a resulting high GA-Hb/AA-Hb ratio. It should be noted that an EPHX1 polymorphisms with a low activity can be compensated for by increased expression (Hosagrahara et al., 2004; Omiecinski et al., 2000). Other combinations of the alleles studied here did not exhibit any indication of significant association (data not shown).
###end p 48
###begin p 49
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 240 263 240 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Ollikainen <italic>et al.</italic>, 1998</xref>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 342 359 342 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Fost <italic>et al.</italic>, 1995</xref>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 372 394 372 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Paulsson <italic>et al.</italic> (2005)</xref>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 610 616 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 601 622 601 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Paulsson <italic>et al.</italic>, 2005</xref>
###xml 655 663 655 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 957 967 957 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro N</italic>
###xml 1067 1073 1067 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1060 1079 1060 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ryberg <italic>et al.</italic>, 1997</xref>
###xml 1088 1094 1088 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1081 1100 1081 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Salama <italic>et al.</italic>, 1999</xref>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 232 238 <span type="species:ncbi:9606">humans</span>
###xml 702 708 <span type="species:ncbi:9606">humans</span>
It has previously been shown that the lack of the GSTT1 gene increases the genotoxic effects of styrene-7,8-oxide in human whole-blood lymphocyte cultures, suggesting that GSTT1 is involved in the detoxification of styrene oxide in humans (Ollikainen et al., 1998). A positive association has also been reported for ethylene oxide and GSTT1 (Fost et al., 1995). Recently, Paulsson et al. (2005) studied the Hb-adduct levels after in vitro incubation of blood from various donors with AA or GA, and reported that the polymorphisms in the GSTT1 or GSTM1 genes did not affect the adduct levels in blood (Paulsson et al., 2005). This was however a short-term in vitro exposure whereas our results are from humans, chronically exposed to AA primarily via the diet. The GSTM1 gene is one of the most studied genes related to metabolic polymorphisms and cancer risk. The GSTM1 null genotype has been shown to increase the frequency of chromosome aberrations after in vitro N-nitrosamine exposure, and in addition, it has been shown to modulate PAH DNA adduct levels (Ryberg et al., 1997; Salama et al., 1999).
###end p 49
###begin p 50
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 92 112 92 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ryberg <italic>et al.</italic> (1997)</xref>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 342 361 342 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ryberg <italic>et al.</italic>, 1997</xref>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 562 583 562 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Wenzlaff <italic>et al.</italic>, 2005</xref>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 739 762 739 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Butkiewicz <italic>et al.</italic>, 1998</xref>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 764 783 764 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Ichiba <italic>et al.</italic>, 1994</xref>
###xml 792 798 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 785 804 785 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Ryberg <italic>et al.</italic>, 1997</xref>
###xml 547 554 <span type="species:ncbi:4097">tobacco</span>
Interactions between several polymorphic variants have been reported for other xenobiotics. Ryberg et al. (1997) studied the interaction between GSTM1 null and GSTP1 105Val genotypes, and observed that individuals with this combination had significantly higher PAH DNA adduct levels in their lung tissue than the other genotype combinations (Ryberg et al., 1997). Another study has shown that the GSTM1 null and GSTP1 105Val allele combination was associated with a four times increased risk of lung cancer in individuals exposed to environmental tobacco smoke (Wenzlaff et al., 2005). The GSTM1 genotype has been shown to modulate the levels of PAH DNA adducts, in an interaction with other genotypes, particularly with GSTP1 and CYP1A1 (Butkiewicz et al., 1998; Ichiba et al., 1994; Ryberg et al., 1997). In our study of AA, we observed a similar interaction between the CYP-dependent activation and the GST-dependent deactivation.
###end p 50
###begin p 51
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 111 135 111 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Brantsaeter <italic>et al.</italic>, 2008</xref>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The intake of AA via food may vary markedly between individuals as indicated by food frequency questionnaires (Brantsaeter et al., 2008). This variation, but also the genotype combination as suggested in our study, would be expected to contribute to the overall risk of individuals for AA-associated disease such as neurotoxicity and cancer. In particular this applies to the GSTM1 null genotype, which in addition to increasing the relative and absolute internal dose of GA also tends to increase the internal AA dose (p = 0.053). A larger study group would needed to confirm these findings, because the data in the present work are based on relatively few individuals. The gene-environment interaction may therefore be taken into account in the analysis of epidemiological data.
###end p 51
###begin title 52
SUPPLEMENTARY DATA
###end title 52
###begin p 53
 are available online at .
###end p 53
###begin title 54
FUNDING
###end title 54
###begin p 55
###xml 0 54 0 54 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Norwegian Research Council and the European Commission</grant-sponsor>
###xml 70 139 70 133 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Food Quality and Safety (Contract n&#176;FOOD-CT-2003-506820 HEATOX)</grant-sponsor>
Norwegian Research Council and the European Commission, Priority 5 on Food Quality and Safety (Contract ndegreesFOOD-CT-2003-506820 HEATOX).
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
[Supplementary Data]
###end title 57
###begin p 58
This publication reflects the authors' views and not necessarily those of the EC. The information in this document is provided as is and no guarantee or warranty is given that the information is fit for any particular purpose. The user thereof uses the information at its sole risk and liability. We thank Mathias Eriksen and Khalid Mohammad for their excellent technical assistance.
###end p 58
###begin article-title 59
A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies
###end article-title 59
###begin article-title 60
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins
###end article-title 60
###begin article-title 61
###xml 25 30 <span type="species:ncbi:9606">human</span>
Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response
###end article-title 61
###begin article-title 62
Association between lung cancer and microsomal epoxide hydrolase genotypes
###end article-title 62
###begin article-title 63
Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide
###end article-title 63
###begin article-title 64
###xml 53 56 <span type="species:ncbi:9606">man</span>
Biochemical genetics of glutathione-S-transferase in man
###end article-title 64
###begin article-title 65
###xml 83 88 <span type="species:ncbi:9606">women</span>
###xml 131 136 <span type="species:ncbi:9606">Child</span>
Exploration of different methods to assess dietary acrylamide exposure in pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa)
###end article-title 65
###begin article-title 66
###xml 35 40 <span type="species:ncbi:9606">human</span>
Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms
###end article-title 66
###begin article-title 67
Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review
###end article-title 67
###begin article-title 68
Acrylamide: A review of its genotoxicity and an assessment of heritable genetic risk
###end article-title 68
###begin article-title 69
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10116">rats</span>
DNA adducts derived from administration of acrylamide and glycidamide to mice and rats
###end article-title 69
###begin article-title 70
Detection and characterization of novel polymorphisms in the CYP2E1 gene
###end article-title 70
###begin article-title 71
Effects of variation in detoxification rate on dose monitoring through adducts
###end article-title 71
###begin article-title 72
Metabolic gene polymorphism frequencies in control populations
###end article-title 72
###begin article-title 73
Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts
###end article-title 73
###begin article-title 74
Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender
###end article-title 74
###begin article-title 75
###xml 37 42 <span type="species:ncbi:9606">human</span>
Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
###end article-title 76
###begin article-title 77
Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress
###end article-title 77
###begin article-title 78
Maillard reaction and health aspects
###end article-title 78
###begin article-title 79
###xml 23 28 <span type="species:ncbi:9606">human</span>
Functional analysis of human microsomal epoxide hydrolase genetic variants
###end article-title 79
###begin article-title 80
IARC: Acrylamide
###end article-title 80
###begin article-title 81
Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps
###end article-title 81
###begin article-title 82
###xml 101 104 <span type="species:ncbi:10116">rat</span>
A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat
###end article-title 82
###begin article-title 83
###xml 17 22 <span type="species:ncbi:9606">human</span>
Nomenclature for human glutathione transferases
###end article-title 83
###begin article-title 84
###xml 61 64 <span type="species:ncbi:10116">rat</span>
###xml 69 72 <span type="species:ncbi:9606">man</span>
Theta, a new class of glutathione transferases purified from rat and man
###end article-title 84
###begin article-title 85
Acrylamide is formed in the Maillard reaction
###end article-title 85
###begin article-title 86
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta
###end article-title 86
###begin article-title 87
###xml 72 77 <span type="species:ncbi:9606">women</span>
Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study
###end article-title 87
###begin article-title 88
###xml 100 105 <span type="species:ncbi:9606">human</span>
Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes
###end article-title 88
###begin article-title 89
Epoxide hydrolase-Polymorphism and role in toxicology
###end article-title 89
###begin article-title 90
In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
###end article-title 91
###begin article-title 92
###xml 82 88 <span type="species:ncbi:9606">humans</span>
Different affinity of erythrocyte glutathione-S-transferase to methyl chloride in humans
###end article-title 92
###begin article-title 93
###xml 30 35 <span type="species:ncbi:9606">human</span>
Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
###end article-title 93
###begin article-title 94
p53 mutations in lung tumors: Relationship to putative susceptibility markers for cancer
###end article-title 94
###begin article-title 95
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk
###end article-title 95
###begin article-title 96
Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity
###end article-title 96
###begin article-title 97
Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure
###end article-title 97
###begin article-title 98
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 81 84 <span type="species:ncbi:10116">rat</span>
Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide
###end article-title 98
###begin article-title 99
Acrylamide from Maillard reaction products
###end article-title 99
###begin article-title 100
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice
###end article-title 100
###begin article-title 101
###xml 85 89 <span type="species:ncbi:10116">rats</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy
###end article-title 101
###begin article-title 102
###xml 30 34 <span type="species:ncbi:10116">rats</span>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days
###end article-title 102
###begin article-title 103
The International HapMap Project
###end article-title 103
###begin article-title 104
The International HapMap Project Web site
###end article-title 104
###begin article-title 105
Protein adducts: Quantitative and qualitative aspects of their formation, analysis and applications
###end article-title 105
###begin article-title 106
Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
###end article-title 106
###begin article-title 107
###xml 52 59 <span type="species:ncbi:4097">tobacco</span>
GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study
###end article-title 107

